Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Petra Schreiner

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Advanced Materials (Deerfield Beach, Fla.)|March 27, 2023
Optimizing Lipid Nanoparticles for Delivery in PrimatesKieu Lam, Petra Schreiner, Ada Leung, et al.
ACS Nano|April 3, 2024
Silicon Ether Ionizable Lipids Enable Potent mRNA Lipid Nanoparticles with Rapid Tissue ClearanceRichard Holland, Kieu Lam, Sunny Jeng, et al.
Advanced Materials (Deerfield Beach, Fla.)|January 21, 2023
Unsaturated, Trialkyl Ionizable Lipids are Versatile Lipid-Nanoparticle Components for Therapeutic and Vaccine ApplicationsKieu Lam, Ada Leung, Alan Martin, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 8, 2022
Lyophilization provides long-term stability for a lipid nanoparticle-formulated, nucleoside-modified mRNA vaccineHiromi Muramatsu, Kieu Lam, Csaba Bajusz, et al.
Plos One|March 22, 2016
Impact of a CXCL12/CXCR4 Antagonist in Bleomycin (BLM) Induced Pulmonary Fibrosis and Carbon Tetrachloride (CCl4) Induced Hepatic Fibrosis in MiceLeola N Chow, Petra Schreiner, Betina Y Y Ng, et al.
Biomedicines|June 28, 2023
ASL mRNA-LNP Therapeutic for the Treatment of Argininosuccinic Aciduria Enables Survival Benefit in a Mouse ModelOwen Daly, Azita Josefine Mahiny, Sara Majeski, et al.
Nature Communications|January 16, 2026
Optimal murine CD4<sup>+</sup> T cell priming by mRNA-lipid nanoparticle vaccines requires endogenous antigen processingJulia E Rood, Suh Kyung Yoon, Mary K Heard, et al.
Nature Nanotechnology|June 23, 2025
Tailoring the adjuvanticity of lipid nanoparticles by PEG lipid ratio and phospholipid modificationsMáté Vadovics, Wenchen Zhao, Emily F Daley, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Advanced Materials (Deerfield Beach, Fla.)|March 27, 2023
Optimizing Lipid Nanoparticles for Delivery in PrimatesKieu Lam, Petra Schreiner, Ada Leung, et al.
ACS Nano|April 3, 2024
Silicon Ether Ionizable Lipids Enable Potent mRNA Lipid Nanoparticles with Rapid Tissue ClearanceRichard Holland, Kieu Lam, Sunny Jeng, et al.
Advanced Materials (Deerfield Beach, Fla.)|January 21, 2023
Unsaturated, Trialkyl Ionizable Lipids are Versatile Lipid-Nanoparticle Components for Therapeutic and Vaccine ApplicationsKieu Lam, Ada Leung, Alan Martin, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 8, 2022
Lyophilization provides long-term stability for a lipid nanoparticle-formulated, nucleoside-modified mRNA vaccineHiromi Muramatsu, Kieu Lam, Csaba Bajusz, et al.
Plos One|March 22, 2016
Impact of a CXCL12/CXCR4 Antagonist in Bleomycin (BLM) Induced Pulmonary Fibrosis and Carbon Tetrachloride (CCl4) Induced Hepatic Fibrosis in MiceLeola N Chow, Petra Schreiner, Betina Y Y Ng, et al.
Biomedicines|June 28, 2023
ASL mRNA-LNP Therapeutic for the Treatment of Argininosuccinic Aciduria Enables Survival Benefit in a Mouse ModelOwen Daly, Azita Josefine Mahiny, Sara Majeski, et al.
Nature Communications|January 16, 2026
Optimal murine CD4<sup>+</sup> T cell priming by mRNA-lipid nanoparticle vaccines requires endogenous antigen processingJulia E Rood, Suh Kyung Yoon, Mary K Heard, et al.
Nature Nanotechnology|June 23, 2025
Tailoring the adjuvanticity of lipid nanoparticles by PEG lipid ratio and phospholipid modificationsMáté Vadovics, Wenchen Zhao, Emily F Daley, et al.
Pageof 1